263 related articles for article (PubMed ID: 1850695)
1. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins.
Wasylyk C; Gutman A; Nicholson R; Wasylyk B
EMBO J; 1991 May; 10(5):1127-34. PubMed ID: 1850695
[TBL] [Abstract][Full Text] [Related]
2. A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene.
Buttice G; Kurkinen M
J Biol Chem; 1993 Apr; 268(10):7196-204. PubMed ID: 8463255
[TBL] [Abstract][Full Text] [Related]
3. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
Hagman J; Grosschedl R
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic conversion alters the transcriptional properties of ets.
Wasylyk C; Wasylyk B
Cell Growth Differ; 1992 Sep; 3(9):617-25. PubMed ID: 1329927
[TBL] [Abstract][Full Text] [Related]
5. The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1.
Bosselut R; Duvall JF; Gégonne A; Bailly M; Hémar A; Brady J; Ghysdael J
EMBO J; 1990 Oct; 9(10):3137-44. PubMed ID: 2209540
[TBL] [Abstract][Full Text] [Related]
6. p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter.
Jayaraman G; Srinivas R; Duggan C; Ferreira E; Swaminathan S; Somasundaram K; Williams J; Hauser C; Kurkinen M; Dhar R; Weitzman S; Buttice G; Thimmapaya B
J Biol Chem; 1999 Jun; 274(24):17342-52. PubMed ID: 10358095
[TBL] [Abstract][Full Text] [Related]
7. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2.
Yang BS; Hauser CA; Henkel G; Colman MS; Van Beveren C; Stacey KJ; Hume DA; Maki RA; Ostrowski MC
Mol Cell Biol; 1996 Feb; 16(2):538-47. PubMed ID: 8552081
[TBL] [Abstract][Full Text] [Related]
8. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression.
Langer SJ; Bortner DM; Roussel MF; Sherr CJ; Ostrowski MC
Mol Cell Biol; 1992 Dec; 12(12):5355-62. PubMed ID: 1448070
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C.
McDonnell SE; Kerr LD; Matrisian LM
Mol Cell Biol; 1990 Aug; 10(8):4284-93. PubMed ID: 2115124
[TBL] [Abstract][Full Text] [Related]
10. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
[TBL] [Abstract][Full Text] [Related]
11. The Ets family of transcription factors.
Wasylyk B; Hahn SL; Giovane A
Eur J Biochem; 1993 Jan; 211(1-2):7-18. PubMed ID: 8425553
[TBL] [Abstract][Full Text] [Related]
12. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.
Sgouras DN; Athanasiou MA; Beal GJ; Fisher RJ; Blair DG; Mavrothalassitis GJ
EMBO J; 1995 Oct; 14(19):4781-93. PubMed ID: 7588608
[TBL] [Abstract][Full Text] [Related]
13. Oncogenes control stromelysin and collagenase gene expression.
Butticé G; Kurkinen M
Contrib Nephrol; 1994; 107():101-7. PubMed ID: 8004955
[No Abstract] [Full Text] [Related]
14. Ets-1 and Ets-2 protooncogene expression in theca cells of the adult mouse ovary.
Rowe A; Propst F
Exp Cell Res; 1992 Sep; 202(1):199-202. PubMed ID: 1511734
[TBL] [Abstract][Full Text] [Related]
15. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
16. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions.
Albanese C; Johnson J; Watanabe G; Eklund N; Vu D; Arnold A; Pestell RG
J Biol Chem; 1995 Oct; 270(40):23589-97. PubMed ID: 7559524
[TBL] [Abstract][Full Text] [Related]
17. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation.
Wasylyk B; Wasylyk C; Flores P; Begue A; Leprince D; Stehelin D
Nature; 1990 Jul; 346(6280):191-3. PubMed ID: 2114554
[TBL] [Abstract][Full Text] [Related]
18. Expression of a 91-kilodalton PEA3-binding protein is down-regulated during differentiation of F9 embryonal carcinoma cells.
Martin ME; Yang XY; Folk WR
Mol Cell Biol; 1992 May; 12(5):2213-21. PubMed ID: 1569949
[TBL] [Abstract][Full Text] [Related]
19. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site.
Nicholson RC; Mader S; Nagpal S; Leid M; Rochette-Egly C; Chambon P
EMBO J; 1990 Dec; 9(13):4443-54. PubMed ID: 2176152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
